About Us

ABOUT

BioStem Technologies

BioStem Technologies, Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived allografts for advanced wound care. Since our founding in 2014, we’ve pursued a singular goal: changing lives for the better with the power of superior processes and an unwavering commitment to innovation.

Leveraging our proprietary BioREtain® processing method, we manufacture perinatal tissue allografts at the highest levels of quality. BioREtain has been developed by applying the latest research in regenerative medicine, focused on maintaining natural growth factors and preserving tissue structure. Our allografts, including VENDAJE®, VENDAJE AC®, VENDAJE OPTIC® and AmnioWrap2TM are trusted by top clinicians across a range of specialties.

BioStem Lab

Mission Statement

We Manufacture Products That Change Lives™

Vision

To become synonymous for excellence in the development and production of life-changing products.  

Core Values

Quality

We adhere to the highest quality standards set forth by prestigious industry regulators such as AATB® and FDA®.

Compassion

Our motto is more than just a clever saying, it’s how we govern our practices.

Innovation

By developing novel approaches to industry changing processes, we focus on better than status quo.

Management Team

Jason Matuszewski

Chief Executive Officer

Andrew Van Vurst, CTBS

Chief Operating Officer

Michael Fortunato, CPA

Chief Financial Officer

Shawn McCarrey

Chief Commercial Officer

Neal Bhattacharya, MBA

Vice President of Marketing

Dr. Wendy W. Weston, PhD, CTBS

Vice President of R&D

Board of Directors

Thomas Dugan

Chairman of the Board

Jason Matuszewski

Chief Executive Officer

Brandon Poe

Chairman of Audit Committee and Board Member

Andrew Van Vurst, CTBS

Board Member

Kenneth Warrington, Ph.D.

Board and Audit Committee Member

Patrick Daly

Chairman of the Comp Committee. Board and Audit Committee Member

Scientific Advisory Board

Kenneth Warrington, Ph.D.

Chairman of the Board

Shaun Opie, Ph.D.

Board Member